Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ching-Feng Lien

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Head & Neck|January 31, 2026
Response to Letter to the Editor: Fully COVID-19 Vaccinated Status Enhanced the Efficacy of Immune Checkpoint Inhibitors in Patients With Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaChien-Chung Wang, Chih-Chun Wang, Chuan-Chien Yang, et al.
Cancers|May 28, 2022
Treatment Sequences in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Cetuximab Followed by Immunotherapy or Vice VersaChuan-Chien Yang, Ching-Feng Lien, Tzer-Zen Hwang, et al.
Head & Neck|November 20, 2025
Fully COVID-19 Vaccinated Status Enhanced the Efficacy of Immune Checkpoint Inhibitors in Patients With Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaChien-Chung Wang, Chih-Chun Wang, Chuan-Chien Yang, et al.
Cancers|September 23, 2022
Platinum Plus Tegafur-Uracil versus Platinum Alone during Concurrent Chemoradiotherapy in Patients with Nonmetastatic Nasopharyngeal Carcinoma: A Propensity-Score-Matching AnalysisChing-Feng Lien, Chien-Chung Wang, Chuan-Chien Yang, et al.
Biology|October 23, 2021
Tegafur-Uracil versus 5-Fluorouracil in Combination with Cisplatin and Cetuximab in Elderly Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Propensity Score Matching AnalysisMeng-Che Hsieh, Chih-Chun Wang, Chuan-Chien Yang, et al.
Oral Oncology|April 1, 2022
The role of induction chemotherapy in patients with locally advanced head and neck squamous cell carcinoma: A nationwide population-based matched studyMeng-Che Hsieh, Chih-Chun Wang, Chuan-Chien Yang, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|July 17, 2025
Efficacy and Safety of a Magnetic Device for Temporary Management of Blepharoptosis: Single-Arm Open-Label TrialChing-Feng Lien, Bor-Shyh Lin, Tzong-Ming Wu, et al.
Biomolecules|March 25, 2022
NAMPT Inhibitor and P73 Activator Represses P53 R175H Mutated HNSCC Cell Proliferation in a Synergistic MannerBi-He Cai, Zhi-Yu Bai, Ching-Feng Lien, et al.
American Journal of Cancer Research|December 7, 2023
Prognostic impact of cortactin in patients with hypopharyngeal cancer and its role for tegafur-uracil maintenance after adjuvant chemoradiotherapyChing-Feng Lien, Tzer-Zen Hwang, Tsun-Mei Lin, et al.
European Journal of Clinical Pharmacology|June 10, 2026
Efficacy of NEPA for prevention of chemotherapy induced nausea and vomiting in head and neck cancer patients receiving cisplatin-based chemotherapyTzer-Zen Hwang, Chih-Chun Wang, Chuan-Chien Yang, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Head & Neck|January 31, 2026
Response to Letter to the Editor: Fully COVID-19 Vaccinated Status Enhanced the Efficacy of Immune Checkpoint Inhibitors in Patients With Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaChien-Chung Wang, Chih-Chun Wang, Chuan-Chien Yang, et al.
Cancers|May 28, 2022
Treatment Sequences in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Cetuximab Followed by Immunotherapy or Vice VersaChuan-Chien Yang, Ching-Feng Lien, Tzer-Zen Hwang, et al.
Head & Neck|November 20, 2025
Fully COVID-19 Vaccinated Status Enhanced the Efficacy of Immune Checkpoint Inhibitors in Patients With Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaChien-Chung Wang, Chih-Chun Wang, Chuan-Chien Yang, et al.
Cancers|September 23, 2022
Platinum Plus Tegafur-Uracil versus Platinum Alone during Concurrent Chemoradiotherapy in Patients with Nonmetastatic Nasopharyngeal Carcinoma: A Propensity-Score-Matching AnalysisChing-Feng Lien, Chien-Chung Wang, Chuan-Chien Yang, et al.
Biology|October 23, 2021
Tegafur-Uracil versus 5-Fluorouracil in Combination with Cisplatin and Cetuximab in Elderly Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Propensity Score Matching AnalysisMeng-Che Hsieh, Chih-Chun Wang, Chuan-Chien Yang, et al.
Oral Oncology|April 1, 2022
The role of induction chemotherapy in patients with locally advanced head and neck squamous cell carcinoma: A nationwide population-based matched studyMeng-Che Hsieh, Chih-Chun Wang, Chuan-Chien Yang, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|July 17, 2025
Efficacy and Safety of a Magnetic Device for Temporary Management of Blepharoptosis: Single-Arm Open-Label TrialChing-Feng Lien, Bor-Shyh Lin, Tzong-Ming Wu, et al.
Biomolecules|March 25, 2022
NAMPT Inhibitor and P73 Activator Represses P53 R175H Mutated HNSCC Cell Proliferation in a Synergistic MannerBi-He Cai, Zhi-Yu Bai, Ching-Feng Lien, et al.
American Journal of Cancer Research|December 7, 2023
Prognostic impact of cortactin in patients with hypopharyngeal cancer and its role for tegafur-uracil maintenance after adjuvant chemoradiotherapyChing-Feng Lien, Tzer-Zen Hwang, Tsun-Mei Lin, et al.
European Journal of Clinical Pharmacology|June 10, 2026
Efficacy of NEPA for prevention of chemotherapy induced nausea and vomiting in head and neck cancer patients receiving cisplatin-based chemotherapyTzer-Zen Hwang, Chih-Chun Wang, Chuan-Chien Yang, et al.
Pageof 4